News

Mycobacterium tuberculosis (green) inside human immune cells known as macrophages. (Credit: Av-Gay Lab)

Seventy-year-old Parkinson’s drug shows promise against tuberculosis

New UBC study reveals benztropine’s potential to treat the world’s deadliest infectious disease and combat growing antibiotic resistance.   Mycobacterium ...

New molecular label could lead to simpler, faster tuberculosis tests

Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world's deadliest ...

Researchers use AI to improve diagnosis of drug-resistant infections

Method outperforms current WHO standard in predicting resistance, aiding faster, more accurate treatments. Source: Tulane University Summary: Scientists have developed ...

Self-destructing vaccine offers enhanced protection against tuberculosis in monkeys

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of ...

How a new gut microbe drives the gut-lung axis

A team has discovered a new communication pathway between the gut and lung. Their findings highlight how a little-known member ...

Peat-bog fungi produce substances that kill tuberculosis-causing bacteria

An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to the bacterium that ...
4th International Congress of Asian African Society of Mycobacteriology

4th International Congress of Asian African Society of Mycobacteriology

  The Asian African Society of Mycobacteriology is pleased to invite you to submit an abstract between 15 February 2024 ...

Tuberculosis and Nontuberculous Mycobacteria Online Course (Four-Weeks) About Course: Tuberculosis is the leading infectious disease killer and the ninth cause ...

The Fine Art of Administering a Tuberculin Skin Test

Tuberculosis is an airborne disease with serious medical consequences. It is caused by the bacterium Mycobacterium tuberculosis, which belongs to ...

Study validates shorter treatment for major world infection, tuberculosis

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month ...

TB immune response discovery could significantly reduce disease harm

A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis ...

Tuberculosis Alone and With HIV Co-Infection: Treatment Updates

In patients with a history of tuberculosis (TB), the odds of residual pulmonary impairments are 2- to 3-fold higher compared ...